NPI: 1700845278 · LYNWOOD, CA 90262 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/22/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/22/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,705 | $3.54M |
| 2019 | 13,836 | $1.76M |
| 2020 | 21,973 | $2.53M |
| 2021 | 28,266 | $2.63M |
| 2022 | 17,243 | $2.52M |
| 2023 | 17,424 | $2.91M |
| 2024 | 16,023 | $2.51M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 66,139 | 6,765 | $12.82M |
| 0821 | 5,432 | 1,340 | $4.88M | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 20,856 | 2,715 | $317K |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,279 | 1,668 | $180K |
| J1756 | Injection, iron sucrose, 1 mg | 10,137 | 3,365 | $91K |
| A4657 | Syringe, with or without needle, each | 9,277 | 2,632 | $71K |
| 0250 | 3,082 | 211 | $24K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,239 | 691 | $17K |
| 83970 | 1,573 | 1,545 | $3K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 87 | 67 | $3K |
| 90674 | 190 | 189 | $3K | |
| 90662 | 124 | 120 | $2K | |
| 82108 | 274 | 271 | $859.20 | |
| 82728 | 610 | 590 | $850.41 | |
| 90670 | 13 | 13 | $690.42 | |
| 83550 | 550 | 534 | $465.49 | |
| 83540 | 640 | 621 | $346.37 | |
| 90661 | 12 | 12 | $338.52 | |
| 85041 | 1,275 | 1,206 | $271.01 | |
| 85048 | 1,307 | 1,238 | $228.88 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 40 | 35 | $219.81 |
| 86706 | 20 | 20 | $172.22 | |
| G0008 | Administration of influenza virus vaccine | 70 | 67 | $134.61 |
| 0302 | 138 | 118 | $109.32 | |
| 85045 | 106 | 91 | $0.00 |